fb-pixel Skip to main content
Health and biotech

Latest stories

More biotech and health care stories


One mother’s healing walk brings marginalized communities together for environmental justice

One week before Indigenous People’s Day, Judith Foster held her first major walk and environmental program since the pandemic

New nasal spray vaccines might reduce COVID infections, but the money is still missing

New nasal spray vaccines might reduce COVID infections and cut off transmission, but data supporting the approach, and funding for clinical trials, is scant.

Brie, Camembert cheeses recalled after listeria cases in multiple states, including Massachusetts

Old Europe Cheese distributes products to supermarkets and grocery stores across the country, including Shaw’s, Whole Foods, Stop & Shop, and Market Basket, the company’s statement said.

Children’s winter viruses strike early, filling ICUs

The viruses of winter arrived early this year, and hospitals and doctor’s offices are filling up with sniffling and coughing children.

BEYOND ROE

On abortion, intimidation is in the eye of the beholder

Conservatives want a 1994 law protecting reproductive health care providers to protect antiabortion pregnancy centers too.

HOMELESSNESS

Could an Olmstead plan solve part of R.I.’s homeless problem?

Rhode Island is one of just seven states with no plan in place to help homeless residents who struggle with disabilities, addiction, and other issues. Advocates are pushing the governor to create one.

Price of Cambridge biotech’s new ALS drug criticized by watchdog group

It says the $158,000 annual cost per patient isn’t justified, based on the medicine’s effectiveness.

Cambridge biotech wins approval for much-debated ALS drug

The closely watched drug, called Relyvrio, was developed by Amylyx Pharmaceuticals, a biotech founded in 2013 by two Brown University graduates.